RÉSUMÉ
Anorectics are clinically used in the management of obesity to accept dietary restriction through decreased desire of food intake. The present study, indicates that the drug SK & F 38393 a dopamine agonist given to albino rats at the doses of 1 mg/kg and 5 mg/kg caused decreased food intake. Central side effects observed with amphetamine and other related drugs were not observed with this drug. The drug thus may be used as an anorectic agent without central side effects.
Sujet(s)
1-Phényl-2,3,4,5-tétrahydro-1H-3-benzazépine-7,8-diol , Animaux , Anorexigènes/pharmacologie , Benzazépines/effets indésirables , Poids/effets des médicaments et des substances chimiques , Rats , Récepteurs dopaminergiques/effets des médicaments et des substances chimiquesRÉSUMÉ
Injection of heparin as well as antigenic challenge in sensitized guinea pigs are known to produce a release of histaminase into the plasma. In the present study, tissue histaminase estimation was done by Spencer's method (17) and plasma estimation by Kapellar Adler's (7) method. Mepyramine pretreatment considerably decreased the histaminase release by both heparin and anaphylaxis. Mepyramine did not antagonise the anticoagulant action of heparin in vitro.